Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	aspartic-type endopeptidase activity	ERVK-6 ERVK-7 ERVK-21 ERVK-9 ERVK-10 ERVK-8 ERVK-19 ERVK-24	7.94e-12	37	97	8	GO:0004190
GeneOntologyMolecularFunction	aspartic-type peptidase activity	ERVK-6 ERVK-7 ERVK-21 ERVK-9 ERVK-10 ERVK-8 ERVK-19 ERVK-24	1.00e-11	38	97	8	GO:0070001
GeneOntologyMolecularFunction	zinc ion binding	ERVK-6 HIVEP1 TES TRIM31 CHD3 ERVK-7 ERVK-21 ERVK-9 ERVK-10 ZMAT3 RBSN ZFHX4 ERVK-8 ERVK-5 ERVK-19 RORA ZFR ERVK-24 TRIM37	4.70e-08	891	97	19	GO:0008270
GeneOntologyMolecularFunction	RNA-DNA hybrid ribonuclease activity	ERVK-6 ERVK-7 ERVK-10 ERVK-8	1.68e-07	11	97	4	GO:0004523
GeneOntologyMolecularFunction	RNA-directed DNA polymerase activity	ERVK-6 ERVK-7 ERVK-10 ERVK-8	5.05e-07	14	97	4	GO:0003964
GeneOntologyMolecularFunction	transition metal ion binding	ERVK-6 HIVEP1 TES TRIM31 CHD3 ERVK-7 ERVK-21 ERVK-9 ERVK-10 PPEF1 ZMAT3 RBSN ZFHX4 ERVK-8 ERVK-5 ERVK-19 RORA ZFR ERVK-24 TRIM37	8.99e-07	1189	97	20	GO:0046914
GeneOntologyMolecularFunction	RNA stem-loop binding	ERVK-6 ERVK-7 ERVK-10 ERVK-8	2.94e-06	21	97	4	GO:0035613
GeneOntologyMolecularFunction	RNA endonuclease activity, producing 5'-phosphomonoesters	ERVK-6 ERVK-7 ERVK-10 ERVK-8	3.06e-05	37	97	4	GO:0016891
GeneOntologyMolecularFunction	DNA polymerase activity	ERVK-6 ERVK-7 ERVK-10 ERVK-8	3.40e-05	38	97	4	GO:0034061
GeneOntologyMolecularFunction	endopeptidase activity	ERVK-6 RHBDL1 ERVK-7 ERVK-21 ERVK-9 ERVK-10 CLCA1 ERVK-8 ERVK-19 ERVK-24	4.58e-05	430	97	10	GO:0004175
GeneOntologyMolecularFunction	endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters	ERVK-6 ERVK-7 ERVK-10 ERVK-8	7.30e-05	46	97	4	GO:0016893
GeneOntologyMolecularFunction	nucleotidyltransferase activity	ERVK-6 PARP3 ERVK-7 ERVK-10 PARP4 ERVK-8	9.85e-05	152	97	6	GO:0016779
GeneOntologyMolecularFunction	(1->3)-beta-D-glucan binding	CLEC4M CD209	1.39e-04	4	97	2	GO:0001872
GeneOntologyMolecularFunction	histone H3K36 trimethyltransferase activity	SETD2 SETD5	2.31e-04	5	97	2	GO:0140955
GeneOntologyMolecularFunction	peptidase activity	ERVK-6 RHBDL1 ERVK-7 ERVK-21 ERVK-9 ERVK-10 CLCA1 ERVK-8 ERVK-19 ERVK-24 MINDY1	3.31e-04	654	97	11	GO:0008233
GeneOntologyMolecularFunction	RNA endonuclease activity	ERVK-6 ERVK-7 ERVK-10 ERVK-8	5.95e-04	79	97	4	GO:0004521
GeneOntologyMolecularFunction	virion binding	CLEC4M CD209	1.02e-03	10	97	2	GO:0046790
GeneOntologyMolecularFunction	cadherin binding	TES KTN1 PTPRT PPL HNRNPK GOLGA2 PLIN3	1.33e-03	339	97	7	GO:0045296
GeneOntologyMolecularFunction	histone H3K36 methyltransferase activity	SETD2 SETD5	1.76e-03	13	97	2	GO:0046975
GeneOntologyMolecularFunction	diacylglycerol-dependent serine/threonine kinase activity	PRKD2 PRKD3	2.68e-03	16	97	2	GO:0004697
GeneOntologyBiologicalProcess	viral process	ERVK-6 TRIM31 SRPK1 ERVK-7 ERVK-21 ERVK-9 ERVK-10 CLEC4M CD209 ERVK-8 ERVK-5 ERVK-19 ERVK-24	3.02e-07	464	98	13	GO:0016032
GeneOntologyBiologicalProcess	DNA integration	ERVK-6 ERVK-7 ERVK-10 ERVK-8	3.32e-07	13	98	4	GO:0015074
GeneOntologyBiologicalProcess	DNA biosynthetic process	MYC ERVK-6 PRKD2 PARP3 ERVK-7 ERVK-10 PARP4 ERVK-8	9.53e-06	218	98	8	GO:0071897
GeneOntologyBiologicalProcess	RNA-templated DNA biosynthetic process	ERVK-6 ERVK-7 ERVK-10 PARP4 ERVK-8	4.73e-05	83	98	5	GO:0006278
GeneOntologyBiologicalProcess	cell-cell fusion	ERVK-6 ERVK-21 ERVK-9 ERVK-8 ERVK-19	5.30e-05	85	98	5	GO:0140253
GeneOntologyBiologicalProcess	syncytium formation by plasma membrane fusion	ERVK-6 ERVK-21 ERVK-9 ERVK-8 ERVK-19	5.30e-05	85	98	5	GO:0000768
GeneOntologyBiologicalProcess	syncytium formation	ERVK-6 ERVK-21 ERVK-9 ERVK-8 ERVK-19	6.61e-05	89	98	5	GO:0006949
GeneOntologyBiologicalProcess	B cell adhesion	CLEC4M CD209	6.68e-05	3	98	2	GO:0097323
GeneOntologyBiologicalProcess	peptide antigen transport	CLEC4M CD209	6.68e-05	3	98	2	GO:0046968
GeneOntologyBiologicalProcess	DNA synthesis involved in DNA repair	ERVK-6 ERVK-7 ERVK-10 ERVK-8	7.94e-05	48	98	4	GO:0000731
GeneOntologyBiologicalProcess	detection of yeast	CLEC4M CD209	1.33e-04	4	98	2	GO:0001879
GeneOntologyBiologicalProcess	endoplasmic reticulum tubular network membrane organization	ATL1 ATL2	1.33e-04	4	98	2	GO:1990809
GeneOntologyBiologicalProcess	endoplasmic reticulum tubular network organization	ATL3 ATL1 ATL2	1.50e-04	22	98	3	GO:0071786
GeneOntologyBiologicalProcess	detection of fungus	CLEC4M CD209	2.21e-04	5	98	2	GO:0016046
GeneOntologyBiologicalProcess	DNA recombination	ERVK-6 PARP3 ERVK-7 ERVK-10 SETD2 KLHL15 ERVK-8 KPNA1	3.71e-04	368	98	8	GO:0006310
GeneOntologyCellularComponent	endoplasmic reticulum tubular network membrane	ATL3 ATL1 ATL2	9.92e-07	5	98	3	GO:0098826
Domain	GBP_C	ATL3 ATL1 ATL2	1.23e-05	10	89	3	PF02841
Domain	G_GB1_RHD3_dom	ATL3 ATL1 ATL2	1.68e-05	11	89	3	IPR030386
Domain	Guanylate-bd_C	ATL3 ATL1 ATL2	1.68e-05	11	89	3	IPR003191
Domain	GBP	ATL3 ATL1 ATL2	1.68e-05	11	89	3	PF02263
Domain	Guanylate-bd_N	ATL3 ATL1 ATL2	1.68e-05	11	89	3	IPR015894
Domain	G_GB1_RHD3	ATL3 ATL1 ATL2	1.68e-05	11	89	3	PS51715
Domain	BAT2_N	PRRC2C PRRC2B	6.72e-05	3	89	2	PF07001
Domain	Protein_Kinase_C_mu-related	PRKD2 PRKD3	6.72e-05	3	89	2	IPR015727
Domain	BAT2_N	PRRC2C PRRC2B	6.72e-05	3	89	2	IPR009738
Domain	PRRC2	PRRC2C PRRC2B	6.72e-05	3	89	2	IPR033184
Domain	-	PARP3 PARP4	1.34e-04	4	89	2	1.20.142.10
Domain	PARP_ALPHA_HD	PARP3 PARP4	1.34e-04	4	89	2	PS51060
Domain	Poly(ADP-ribose)pol_reg_dom	PARP3 PARP4	1.34e-04	4	89	2	IPR004102
Domain	Znf_C2H2_jaz	ZMAT3 PRDM10 ZFR	1.51e-04	22	89	3	IPR022755
Domain	zf-C2H2_jaz	ZMAT3 PRDM10 ZFR	1.51e-04	22	89	3	PF12171
Domain	ZnF_U1	ZMAT3 ZFHX4 ZFR	3.49e-04	29	89	3	SM00451
Domain	Znf_U1	ZMAT3 ZFHX4 ZFR	3.49e-04	29	89	3	IPR003604
Domain	Znf_C2H2-like	SP2 SP3 HIVEP1 ZNF518A HINFP ZMAT3 RBSN PRDM10 ZFHX4 ZNF335 ZFR ZNF292	3.85e-04	796	89	12	IPR015880
Domain	ZnF_C2H2	SP2 SP3 HIVEP1 ZNF518A HINFP ZMAT3 RBSN PRDM10 ZFHX4 ZNF335 ZFR ZNF292	4.40e-04	808	89	12	SM00355
Domain	RFX_DNA_binding	RFX8 RFX1	7.91e-04	9	89	2	PF02257
Domain	DNA-bd_RFX	RFX8 RFX1	7.91e-04	9	89	2	IPR003150
Domain	RFX_DBD	RFX8 RFX1	7.91e-04	9	89	2	PS51526
Domain	Sp1_fam	SP2 SP3	9.86e-04	10	89	2	IPR030450
Domain	BTB-kelch_protein	KLHL7 KLHL15 KLHL18	1.12e-03	43	89	3	IPR017096
Domain	ZINC_FINGER_C2H2_1	SP2 SP3 HIVEP1 ZNF518A HINFP RBSN PRDM10 ZFHX4 ZNF335 ZFR ZNF292	1.14e-03	777	89	11	PS00028
Domain	Znf_C2H2	SP2 SP3 HIVEP1 ZNF518A HINFP RBSN PRDM10 ZFHX4 ZNF335 ZFR ZNF292	1.52e-03	805	89	11	IPR007087
Domain	SET_dom	SETD2 PRDM10 SETD5	1.74e-03	50	89	3	IPR001214
Domain	SET	SETD2 PRDM10 SETD5	1.74e-03	50	89	3	PS50280
Domain	Kelch	KLHL7 KLHL15 KLHL18	2.67e-03	58	89	3	SM00612
Domain	Poly(ADP-ribose)pol_cat_dom	PARP3 PARP4	2.91e-03	17	89	2	IPR012317
Domain	PARP_CATALYTIC	PARP3 PARP4	2.91e-03	17	89	2	PS51059
Domain	PARP	PARP3 PARP4	2.91e-03	17	89	2	PF00644
Domain	-	PARP3 PARP4	2.91e-03	17	89	2	3.90.228.10
Domain	BACK	KLHL7 KLHL15 KLHL18	2.94e-03	60	89	3	SM00875
Domain	BACK	KLHL7 KLHL15 KLHL18	3.08e-03	61	89	3	PF07707
Domain	BACK	KLHL7 KLHL15 KLHL18	3.08e-03	61	89	3	IPR011705
Domain	ZINC_FINGER_C2H2_2	SP2 SP3 HIVEP1 ZNF518A HINFP RBSN PRDM10 ZFHX4 ZNF335 ZNF292	3.77e-03	775	89	10	PS50157
Domain	DAG/PE-bd	PRKD2 PRKD3	4.45e-03	21	89	2	IPR020454
Domain	Kelch_1	KLHL7 KLHL15 KLHL18	4.55e-03	70	89	3	PF01344
Domain	Kelch_1	KLHL7 KLHL15 KLHL18	4.55e-03	70	89	3	IPR006652
Domain	G_patch	ERVK-6 AGGF1	5.32e-03	23	89	2	SM00443
Domain	G_patch_dom	ERVK-6 AGGF1	5.32e-03	23	89	2	IPR000467
Domain	G_PATCH	ERVK-6 AGGF1	5.32e-03	23	89	2	PS50174
Domain	G-patch	ERVK-6 AGGF1	5.32e-03	23	89	2	PF01585
Domain	zf-CCHC	ERVK-6 ERVK-5	5.32e-03	23	89	2	PF00098
Domain	-	LNX2 TRIM31 RNF213 CHD3 RBSN ZFYVE9 TRIM37	5.62e-03	449	89	7	3.30.40.10
Domain	zf-C2H2	SP2 SP3 HIVEP1 ZNF518A HINFP PRDM10 ZFHX4 ZNF335 ZNF292	5.72e-03	693	89	9	PF00096
Domain	Znf_C2H2/integrase_DNA-bd	SP2 SP3 HIVEP1 ZNF518A HINFP PRDM10 ZFHX4 ZNF335 ZNF292	5.77e-03	694	89	9	IPR013087
Domain	WGR_domain	PARP3 PARP4	5.79e-03	24	89	2	IPR008893
Domain	Znf_RING/FYVE/PHD	LNX2 TRIM31 RNF213 CHD3 RBSN ZFYVE9 TRIM37	6.31e-03	459	89	7	IPR013083
Domain	FHA	KIF16B AGGF1	7.83e-03	28	89	2	SM00240
Domain	FYVE	RBSN ZFYVE9	8.38e-03	29	89	2	PF01363
Domain	FYVE	RBSN ZFYVE9	8.38e-03	29	89	2	SM00064
Pubmed	A revised nomenclature for transcribed human endogenous retroviral loci.	ERVK-6 ERVK-7 ERVK-21 ERVK-9 ERVK-10 ERVK-8 ERVK-5 ERVK-19 ERVK-24	7.37e-12	94	99	9	21542922
Pubmed	Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans.	ERVK-6 ERVK-7 ERVK-10 ERVK-24	6.18e-11	4	99	4	10469592
Pubmed	Human endogenous retrovirus K10: expression of Gag protein and detection of antibodies in patients with seminomas.	ERVK-6 ERVK-10 ERVK-5 ERVK-19	6.18e-11	4	99	4	7983737
Pubmed	Genomewide screening for fusogenic human endogenous retrovirus envelopes identifies syncytin 2, a gene conserved on primate evolution.	ERVK-6 ERVK-21 ERVK-9 ERVK-8 ERVK-19	1.32e-10	12	99	5	14557543
Pubmed	Quantitation of HERV-K env gene expression and splicing in human breast cancer.	ERVK-6 ERVK-7 ERVK-21 ERVK-19	3.08e-10	5	99	4	12629516
Pubmed	Human atlastin GTPases mediate differentiated fusion of endoplasmic reticulum membranes.	ATL3 ATL1 ATL2	2.24e-08	3	99	3	25773277
Pubmed	Mammalian knock out cells reveal prominent roles for atlastin GTPases in ER network morphology.	ATL3 ATL1 ATL2	2.24e-08	3	99	3	27669642
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	TES KTN1 RFX1 HNRNPK SETD2 PRRC2C ZFR QSER1 AMOTL2 SNRNP200 PLIN3 PRRC2B	5.65e-08	549	99	12	38280479
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	MYC SP2 SP3 HIVEP1 TES MBNL1 CHD3 RFX1 HINFP ZMAT3 TSC22D1 RORA ZFR ZNF292	7.32e-08	808	99	14	20412781
Pubmed	Expression patterns of transcribed human endogenous retrovirus HERV-K(HML-2) loci in human tissues and the need for a HERV Transcriptome Project.	ERVK-21 ERVK-9 ERVK-10 ERVK-24	1.83e-07	18	99	4	18664271
Pubmed	Transcriptionally active HERV-K genes: identification, isolation, and chromosomal mapping.	ERVK-6 ERVK-7 ERVK-5	2.23e-07	5	99	3	11401426
Pubmed	Cooperation of the ER-shaping proteins atlastin, lunapark, and reticulons to generate a tubular membrane network.	ATL3 ATL1 ATL2	2.23e-07	5	99	3	27619977
Pubmed	Human endogenous retrovirus HERV-K(HML-2) proviruses with Rec protein coding capacity and transcriptional activity.	ERVK-6 ERVK-9 ERVK-19	4.45e-07	6	99	3	15063128
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	KNTC1 HIVEP1 MBNL1 CHD3 RFX1 HNRNPK LENG8 PRRC2C ZFR QSER1 SNRNP200 PLIN3 PRRC2B RAI1 ZNF292	5.37e-07	1103	99	15	34189442
Pubmed	A class of dynamin-like GTPases involved in the generation of the tubular ER network.	ATL3 ATL1 ATL2	7.77e-07	7	99	3	19665976
Pubmed	Protrudin binds atlastins and endoplasmic reticulum-shaping proteins and regulates network formation.	ATL3 ATL1 ATL2	7.77e-07	7	99	3	23969831
Pubmed	Intersectin (ITSN) family of scaffolds function as molecular hubs in protein interaction networks.	MBNL1 KIF16B PPL HNRNPK GOLGA2 FCHSD1	8.12e-07	111	99	6	22558309
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	MYC PLEKHG4 KTN1 AGGF1 RFX1 PRDM10 ZFHX4 PRRC2C UTP20 ZFR QSER1 SNRNP200 KPNA1	9.92e-07	857	99	13	25609649
Pubmed	A human MAP kinase interactome.	MYC CASP8AP2 HIVEP1 KTN1 HNRNPK LENG8 TSC22D1 SNRNP200 GOLGA2 WNK2	1.33e-06	486	99	10	20936779
Pubmed	A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration.	HIVEP1 PLEKHG4 PPL HNRNPK LENG8 SETD2 RORA TRIM37 WNK2 PRRC2B KPNA1	1.34e-06	608	99	11	16713569
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	KNTC1 SP2 MAN2B2 KTN1 RNF213 PARP4 TSC22D1 SETD2 SNRNP200 KLHL18	1.51e-06	493	99	10	15368895
Pubmed	The E3 Ubiquitin Ligase SYVN1 Ubiquitinates Atlastins to Remodel the Endoplasmic Reticulum Network.	ATL3 ATL1 ATL2	1.86e-06	9	99	3	32916628
Pubmed	Survey of human genes of retroviral origin: identification and transcriptome of the genes with coding capacity for complete envelope proteins.	ERVK-6 ERVK-21 ERVK-19	2.65e-06	10	99	3	12970426
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	HIVEP1 KTN1 MBNL1 CHD3 RFX1 HNRNPK LENG8 SETD2 PRRC2C ZFR QSER1 SNRNP200 RAI1	3.22e-06	954	99	13	36373674
Pubmed	Lymph Node Mesenchymal and Endothelial Stromal Cells Cooperate via the RANK-RANKL Cytokine Axis to Shape the Sinusoidal Macrophage Niche.	CLEC4M CD209 CLCA1	4.83e-06	12	99	3	31201093
Pubmed	Intrinsic BET inhibitor resistance in SPOP-mutated prostate cancer is mediated by BET protein stabilization and AKT-mTORC1 activation.	CHD3 SETD2 GCC2 AMOTL2	5.22e-06	40	99	4	28805822
Pubmed	Defining the human deubiquitinating enzyme interaction landscape.	PRKD2 HIVEP1 KTN1 AGGF1 PRKD3 GCC2 KLHL15 COPS7B ZFR SNRNP200 KLHL18 PRRC2B KPNA1	5.65e-06	1005	99	13	19615732
Pubmed	A genome-wide screen to identify transcription factors expressed in pelvic Ganglia of the lower urinary tract.	MYC SP2 SP3 HIVEP1 TES MBNL1 AGGF1 RBSN RORA ZFR ZNF292	5.80e-06	709	99	11	22988430
Pubmed	Functional proteomics mapping of a human signaling pathway.	PRKD2 HIVEP1 CHD3 RFX1 PPL ZNF518A MTMR11 ZFYVE9 PLIN3 KPNA1	7.48e-06	591	99	10	15231748
Pubmed	Marginal zone macrophages express a murine homologue of DC-SIGN that captures blood-borne antigens in vivo.	CLEC4M CD209	8.02e-06	2	99	2	12351402
Pubmed	Protection in antibody- and T cell-mediated autoimmune diseases by antiinflammatory IgG Fcs requires type II FcRs.	CLEC4M CD209	8.02e-06	2	99	2	25870292
Pubmed	The C-type lectin SIGNR1 binds Schistosoma mansoni antigens in vitro, but SIGNR1-deficient mice have normal responses during schistosome infection.	CLEC4M CD209	8.02e-06	2	99	2	18981244
Pubmed	Protein kinase d isoforms differentially modulate cofilin-driven directed cell migration.	PRKD2 PRKD3	8.02e-06	2	99	2	24840177
Pubmed	[Genetic polymorphism of dendritic cell-specific ICAM-3 grabbing nonintegrin and DC-SIGNR's exon 4 in Chinese hepatitis C patients].	CLEC4M CD209	8.02e-06	2	99	2	18171520
Pubmed	Differential N-linked glycosylation of human immunodeficiency virus and Ebola virus envelope glycoproteins modulates interactions with DC-SIGN and DC-SIGNR.	CLEC4M CD209	8.02e-06	2	99	2	12502850
Pubmed	Molecular characterization of the murine SIGNR1 gene encoding a C-type lectin homologous to human DC-SIGN and DC-SIGNR.	CLEC4M CD209	8.02e-06	2	99	2	12137941
Pubmed	A novel mechanism of carbohydrate recognition by the C-type lectins DC-SIGN and DC-SIGNR. Subunit organization and binding to multivalent ligands.	CLEC4M CD209	8.02e-06	2	99	2	11384997
Pubmed	Functional and antigenic characterization of human, rhesus macaque, pigtailed macaque, and murine DC-SIGN.	CLEC4M CD209	8.02e-06	2	99	2	11581396
Pubmed	DC-SIGN and L-SIGN: the SIGNs for infection.	CLEC4M CD209	8.02e-06	2	99	2	18458800
Pubmed	Protein kinase Ds promote tumor angiogenesis through mast cell recruitment and expression of angiogenic factors in prostate cancer microenvironment.	PRKD2 PRKD3	8.02e-06	2	99	2	30841931
Pubmed	Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR.	CLEC4M CD209	8.02e-06	2	99	2	12634366
Pubmed	The nine-repeat DC-SIGNR isoform is associated with increased HIV-RNA loads and HIV sexual transmission.	CLEC4M CD209	8.02e-06	2	99	2	20217198
Pubmed	Setd5, but not Setd2, is indispensable for retinal cell survival and proliferation.	SETD2 SETD5	8.02e-06	2	99	2	36349512
Pubmed	Extended neck regions stabilize tetramers of the receptors DC-SIGN and DC-SIGNR.	CLEC4M CD209	8.02e-06	2	99	2	15509576
Pubmed	SIGN-R1, a C-type lectin, enhances apoptotic cell clearance through the complement deposition pathway by interacting with C1q in the spleen.	CLEC4M CD209	8.02e-06	2	99	2	23238564
Pubmed	A MAPK/HNRPK pathway controls BCR/ABL oncogenic potential by regulating MYC mRNA translation.	MYC HNRNPK	8.02e-06	2	99	2	16293596
Pubmed	Expression of human endogenous retrovirus type K envelope glycoprotein in insect and mammalian cells.	ERVK-6 ERVK-19	8.02e-06	2	99	2	9060628
Pubmed	Reconstitution of human atlastin fusion activity reveals autoinhibition by the C terminus.	ATL1 ATL2	8.02e-06	2	99	2	34817557
Pubmed	Role of homozygous DC-SIGNR 5/5 tandem repeat polymorphism in HIV-1 exposed seronegative North Indian individuals.	CLEC4M CD209	8.02e-06	2	99	2	17876530
Pubmed	Specific ICAM-3 grabbing nonintegrin-related 1 (SIGNR1) expressed by marginal zone macrophages is essential for defense against pulmonary Streptococcus pneumoniae infection.	CLEC4M CD209	8.02e-06	2	99	2	16134084
Pubmed	Polymorphisms in DC-SIGN and L-SIGN genes are associated with HIV-1 vertical transmission in a Northeastern Brazilian population.	CLEC4M CD209	8.02e-06	2	99	2	22902397
Pubmed	C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans.	CLEC4M CD209	8.02e-06	2	99	2	12050398
Pubmed	The role of DC-SIGN and DC-SIGNR in HIV and Ebola virus infection: can potential therapeutics block virus transmission and dissemination?	CLEC4M CD209	8.02e-06	2	99	2	12223058
Pubmed	Evolutionary relationships within a subgroup of HERV-K-related human endogenous retroviruses.	ERVK-6 ERVK-19	8.02e-06	2	99	2	9460924
Pubmed	SIGN-R1 and complement factors are involved in the systemic clearance of radiation-induced apoptotic cells in whole-body irradiated mice.	CLEC4M CD209	8.02e-06	2	99	2	26079881
Pubmed	[Analysis of DC-SIGN and DC-SIGNR genetic polymorphism in Chinese Han population].	CLEC4M CD209	8.02e-06	2	99	2	16883544
Pubmed	The clinical significance of DC-SIGN and DC-SIGNR, which are novel markers expressed in human colon cancer.	CLEC4M CD209	8.02e-06	2	99	2	25504222
Pubmed	Utilization of human DC-SIGN and L-SIGN for entry and infection of host cells by the New World arenavirus, Junín virus.	CLEC4M CD209	8.02e-06	2	99	2	24183720
Pubmed	High and low affinity carbohydrate ligands revealed for murine SIGN-R1 by carbohydrate array and cell binding approaches, and differing specificities for SIGN-R3 and langerin.	CLEC4M CD209	8.02e-06	2	99	2	15136555
Pubmed	SIGN-R1 contributes to protection against lethal pneumococcal infection in mice.	CLEC4M CD209	8.02e-06	2	99	2	15583012
Pubmed	Molecular basis of the differences in binding properties of the highly related C-type lectins DC-SIGN and L-SIGN to Lewis X trisaccharide and Schistosoma mansoni egg antigens.	CLEC4M CD209	8.02e-06	2	99	2	15184372
Pubmed	Murine SIGNR1 (CD209b) Contributes to the Clearance of Uropathogenic Escherichia coli During Urinary Tract Infections.	CLEC4M CD209	8.02e-06	2	99	2	31998663
Pubmed	Dynamic populations of dendritic cell-specific ICAM-3 grabbing nonintegrin-positive immature dendritic cells and liver/lymph node-specific ICAM-3 grabbing nonintegrin-positive endothelial cells in the outer zones of the paracortex of human lymph nodes.	CLEC4M CD209	8.02e-06	2	99	2	15111305
Pubmed	Atlastin GTPases are required for Golgi apparatus and ER morphogenesis.	ATL3 ATL2	8.02e-06	2	99	2	18270207
Pubmed	Internalizing antibodies to the C-type lectins, L-SIGN and DC-SIGN, inhibit viral glycoprotein binding and deliver antigen to human dendritic cells for the induction of T cell responses.	CLEC4M CD209	8.02e-06	2	99	2	16365436
Pubmed	Association of CD209 and CD209L polymorphisms with tuberculosis infection in a Northeastern Brazilian population.	CLEC4M CD209	8.02e-06	2	99	2	24874302
Pubmed	Human lectins and their roles in viral infections.	CLEC4M CD209	8.02e-06	2	99	2	25642836
Pubmed	Structural basis for selective recognition of oligosaccharides by DC-SIGN and DC-SIGNR.	CLEC4M CD209	8.02e-06	2	99	2	11739956
Pubmed	C-type lectin receptor SIGNR1 expressed on peritoneal phagocytic cells with an immature dendritic cell-like phenotype is involved in uptake of oligomannose-coated liposomes and subsequent cell maturation.	CLEC4M CD209	8.02e-06	2	99	2	24491912
Pubmed	Opposing growth regulatory roles of protein kinase D isoforms in human keratinocytes.	PRKD2 PRKD3	8.02e-06	2	99	2	25802335
Pubmed	L-SIGN (CD209L) and DC-SIGN (CD209) mediate transinfection of liver cells by hepatitis C virus.	CLEC4M CD209	8.02e-06	2	99	2	15371595
Pubmed	Characterization of DC-SIGN/R interaction with human immunodeficiency virus type 1 gp120 and ICAM molecules favors the receptor's role as an antigen-capturing rather than an adhesion receptor.	CLEC4M CD209	8.02e-06	2	99	2	15795245
Pubmed	Autonomous tetramerization domains in the glycan-binding receptors DC-SIGN and DC-SIGNR.	CLEC4M CD209	8.02e-06	2	99	2	19249311
Pubmed	N-linked glycosylation facilitates sialic acid-independent attachment and entry of influenza A viruses into cells expressing DC-SIGN or L-SIGN.	CLEC4M CD209	8.02e-06	2	99	2	21191006
Pubmed	Mice lacking SIGNR1 have stronger T helper 1 responses to Mycobacterium tuberculosis.	CLEC4M CD209	8.02e-06	2	99	2	17224292
Pubmed	Bortezomib inhibits Burkitt's lymphoma cell proliferation by downregulating sumoylated hnRNP K and c-Myc expression.	MYC HNRNPK	8.02e-06	2	99	2	26317903
Pubmed	Oligomerization domains in the glycan-binding receptors DC-SIGN and DC-SIGNR: Sequence variation and stability differences.	CLEC4M CD209	8.02e-06	2	99	2	27859859
Pubmed	Widely divergent biochemical properties of the complete set of mouse DC-SIGN-related proteins.	CLEC4M CD209	8.02e-06	2	99	2	16682406
Pubmed	Protein kinases D2 and D3 are novel growth regulators in HCC1806 triple-negative breast cancer cells.	PRKD2 PRKD3	8.02e-06	2	99	2	23393329
Pubmed	DC-SIGN and L-SIGN Are Attachment Factors That Promote Infection of Target Cells by Human Metapneumovirus in the Presence or Absence of Cellular Glycosaminoglycans.	CLEC4M CD209	8.02e-06	2	99	2	27334579
Pubmed	Difference in fine specificity to polysaccharides of Candida albicans mannoprotein between mouse SIGNR1 and human DC-SIGN.	CLEC4M CD209	8.02e-06	2	99	2	22331432
Pubmed	DC-SIGN and DC-SIGNR polymorphic variants in Northern Asian Indians.	CLEC4M CD209	8.02e-06	2	99	2	19046307
Pubmed	Association of DC-SIGN and DC-SIGNR Repeat Regions with Susceptibility to Pulmonary Tuberculosis in Zahedan, Southeastern Iran.	CLEC4M CD209	8.02e-06	2	99	2	27309478
Pubmed	Sequence and expression of a membrane-associated C-type lectin that exhibits CD4-independent binding of human immunodeficiency virus envelope glycoprotein gp120.	CLEC4M CD209	8.02e-06	2	99	2	1518869
Pubmed	Comparison of the carbohydrate preference of SIGNR1 as a phagocytic receptor with the preference as an adhesion molecule.	CLEC4M CD209	8.02e-06	2	99	2	24434373
Pubmed	DC-SIGN, DC-SIGNR and LSECtin: C-type lectins for infection.	CLEC4M CD209	8.02e-06	2	99	2	24156700
Pubmed	Glycomimetic ligands block the interaction of SARS-CoV-2 spike protein with C-type lectin co-receptors.	CLEC4M CD209	8.02e-06	2	99	2	35380569
Pubmed	DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2.	CLEC4M CD209	8.02e-06	2	99	2	12609975
Pubmed	CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus.	CLEC4M CD209	8.02e-06	2	99	2	15496474
Pubmed	Protein kinase D3 conditional knockout impairs osteoclast formation and increases trabecular bone volume in male mice.	PRKD2 PRKD3	8.02e-06	2	99	2	37044359
Pubmed	Cloning of GT box-binding proteins: a novel Sp1 multigene family regulating T-cell receptor gene expression.	SP2 SP3	8.02e-06	2	99	2	1341900
Pubmed	Interaction of acute lymphopblastic leukemia cells with C-type lectins DC-SIGN and L-SIGN.	CLEC4M CD209	8.02e-06	2	99	2	18375037
Pubmed	Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins down regulate both DC-SIGN and DC-SIGNR.	CLEC4M CD209	8.02e-06	2	99	2	23460925
Pubmed	Lewis Lung Cancer Cells Promote SIGNR1(CD209b)-Mediated Macrophages Polarization Induced by IL-4 to Facilitate Immune Evasion.	CLEC4M CD209	8.02e-06	2	99	2	26447454
Pubmed	[Relationship between intrauterine infection and the gene polymorphism of DC-SIGN/DC-SIGNR in the pregnant women of HBV positive].	CLEC4M CD209	8.02e-06	2	99	2	22338216
Pubmed	DC-SIGN and DC-SIGNR genetic diversity among different ethnic populations: potential implications for pathogen recognition and disease susceptibility.	CLEC4M CD209	8.02e-06	2	99	2	17509452
Pubmed	HIV-1 transmission by dendritic cell-specific ICAM-3-grabbing nonintegrin (DC-SIGN) is regulated by determinants in the carbohydrate recognition domain that are absent in liver/lymph node-SIGN (L-SIGN).	CLEC4M CD209	8.02e-06	2	99	2	19833723
Pubmed	[Natural selection of DC-SIGN and its homologues L-SIGN and mSIGNR1 in pathogen recognition and innate immunity].	CLEC4M CD209	8.02e-06	2	99	2	16386217
Pubmed	The polymorphisms in DC-SIGNR affect susceptibility to HIV type 1 infection.	CLEC4M CD209	8.02e-06	2	99	2	17530994
Pubmed	Specific asparagine-linked glycosylation sites are critical for DC-SIGN- and L-SIGN-mediated severe acute respiratory syndrome coronavirus entry.	CLEC4M CD209	8.02e-06	2	99	2	17715238
Interaction	FHL2 interactions	MYC SP2 SP3 TES MBNL1 RIBC1 RFX1 ZFYVE9 PRRC2C ZFR QSER1 TRIM37	3.14e-07	396	94	12	int:FHL2
Interaction	SP7 interactions	MYC HIVEP1 MBNL1 CHD3 RFX1 LENG8 ZFHX4 ZFR QSER1 PRRC2B	1.56e-06	304	94	10	int:SP7
Interaction	SNX33 interactions	MYC PRKD2 HNRNPK PRKD3 FCHSD1	1.22e-05	64	94	5	int:SNX33
Interaction	C2CD3 interactions	CEP162 CEP128 HNRNPK TRIM37	1.85e-05	34	94	4	int:C2CD3
Interaction	SUPT5H interactions	MYC HIVEP1 CHD3 HNRNPK LENG8 ZFYVE9 SETD5 ATL2 SNRNP200 GOLGA2	2.06e-05	408	94	10	int:SUPT5H
Interaction	DHX40 interactions	MYC KTN1 LENG8 SETD2 UTP20 SNRNP200 RAI1 KPNA1	2.16e-05	249	94	8	int:DHX40
Interaction	FCRL5 interactions	MYC CAGE1 AMOTL2	2.72e-05	13	94	3	int:FCRL5
Interaction	TACR3 interactions	PRKD2 KTN1 ATL3 LENG8 ATL2	2.82e-05	76	94	5	int:TACR3
Interaction	AKAP8 interactions	MYC TES TRIM31 CHD3 PPEF1 HNRNPK TRIM37	3.36e-05	193	94	7	int:AKAP8
Interaction	KRT6B interactions	MYC KRT32 CHD3 WTAP TRIM37 GOLGA2	3.58e-05	132	94	6	int:KRT6B
Interaction	FBL interactions	MYC KTN1 TRIM31 SRPK1 CHD3 LENG8 PRRC2C UTP20 ZFR TRIM37 PRRC2B KPNA1	4.14e-05	639	94	12	int:FBL
Interaction	FEV interactions	SP2 HIVEP1 RFX1 LENG8 ZFHX4 QSER1 PRRC2B	4.63e-05	203	94	7	int:FEV
Interaction	KRT78 interactions	MYC KRT32 CHD3 WTAP QSER1	5.42e-05	87	94	5	int:KRT78
Interaction	CEBPA interactions	MYC KNTC1 HIVEP1 MBNL1 CHD3 RFX1 WTAP HNRNPK LENG8 PRRC2C ZFR QSER1 SNRNP200 PLIN3 PRRC2B RAI1 ZNF292	5.66e-05	1245	94	17	int:CEBPA
Interaction	CECR2 interactions	MYC SETD2 PRRC2B KPNA1	6.23e-05	46	94	4	int:CECR2
Interaction	RGL1 interactions	ATL3 LENG8 ATL2	7.62e-05	18	94	3	int:RGL1
Interaction	SNRPA interactions	MYC MBNL1 TRIM31 SRPK1 HNRNPK LENG8 SETD2 PRRC2C ZFR SNRNP200	8.38e-05	482	94	10	int:SNRPA
Interaction	ALB interactions	MYC PRKD2 MBNL1 TRIM31 CHD3 WTAP TSC22D1 TRIM37 ZNF292	8.84e-05	391	94	9	int:ALB
Interaction	SF1 interactions	MYC TES TRIM31 HNRNPK ZFR SNRNP200 PRRC2B KPNA1	8.85e-05	304	94	8	int:SF1
Interaction	DCLRE1A interactions	KTN1 TRIM37 KPNA1	1.06e-04	20	94	3	int:DCLRE1A
Interaction	NAGK interactions	LNX2 TES MBNL1 SETD5 PRRC2B RAI1	1.12e-04	162	94	6	int:NAGK
Interaction	DZIP1L interactions	PRKD2 AMOTL2 TRIM37	1.23e-04	21	94	3	int:DZIP1L
Interaction	KRT1 interactions	MYC TRIM31 CHD3 WTAP AMOTL2 TRIM37 GOLGA2	1.25e-04	238	94	7	int:KRT1
Interaction	SNRPB interactions	MYC KNTC1 SP3 SRPK1 CHD3 HNRNPK SETD2 ZFR SNRNP200 GOLGA2	1.49e-04	517	94	10	int:SNRPB
Interaction	SEC16A interactions	MYC TES TRIM31 PPEF1 HNRNPK PRRC2C TRIM37 GOLGA2 PRRC2B	1.69e-04	426	94	9	int:SEC16A
Interaction	CPSF6 interactions	MYC TRIM31 SRPK1 WTAP HNRNPK LENG8 SETD2 ZFR SNRNP200 TRIM37	1.71e-04	526	94	10	int:CPSF6
Interaction	TSSC4 interactions	MYC ATL3 SNRNP200 GOLGA2 KPNA1	1.72e-04	111	94	5	int:TSSC4
Interaction	FXR2 interactions	MYC HIVEP1 TRIM31 CHD3 PRRC2C AMOTL2 TRIM37 GOLGA2 PRRC2B	1.81e-04	430	94	9	int:FXR2
Interaction	SNRNP40 interactions	MYC CASP8AP2 HIVEP1 MBNL1 AGGF1 SRPK1 CHD3 LENG8 SETD2 PRDM10 SNRNP200	1.85e-04	637	94	11	int:SNRNP40
Interaction	HMGXB4 interactions	MYC CHD3 LENG8 TSC22D1 KPNA1	1.87e-04	113	94	5	int:HMGXB4
Interaction	NUP50 interactions	MYC RFX1 TSC22D1 KLHL7 ZFR RAI1 ZNF292 KPNA1	1.95e-04	341	94	8	int:NUP50
Interaction	UGT2B10 interactions	MYC PRKD2	2.13e-04	5	94	2	int:UGT2B10
Interaction	EEF1A1 interactions	MYC PRKD2 CEP162 CAGE1 CHD3 WTAP HNRNPK PRRC2C GCC2 SNRNP200 TRIM37 PLIN3	2.18e-04	762	94	12	int:EEF1A1
Interaction	CINP interactions	MYC SP2 AMOTL2 GOLGA2	2.28e-04	64	94	4	int:CINP
Interaction	APOBEC3C interactions	MYC SRPK1 CHD3 HNRNPK LENG8 ZFR	2.44e-04	187	94	6	int:APOBEC3C
Interaction	TSC22D4 interactions	PRKD2 PPL TSC22D1 GOLGA2 WNK2	2.48e-04	120	94	5	int:TSC22D4
Interaction	TERF2IP interactions	MYC HIVEP1 CHD3 RFX1 WTAP HNRNPK SETD2 QSER1 RAI1 ZNF292	2.52e-04	552	94	10	int:TERF2IP
Interaction	COIL interactions	MYC CASP8AP2 HIVEP1 PLEKHG4 AGGF1 CHD3 UTP20 SNRNP200 ZNF292 KPNA1	2.52e-04	552	94	10	int:COIL
Interaction	BCAS2 interactions	MYC MBNL1 CHD3 GCC2 SNRNP200 GOLGA2 PRRC2B	2.72e-04	270	94	7	int:BCAS2
Interaction	PALLD interactions	MYC TES CEP162 CEP128 TRIM37	2.78e-04	123	94	5	int:PALLD
Interaction	SOX2 interactions	SP2 HIVEP1 SRPK1 CHD3 RFX1 PPL HNRNPK PARP4 SETD2 ZFHX4 CROCC2 ZFR QSER1 AMOTL2 RSPH10B PRRC2B ZNF292	2.82e-04	1422	94	17	int:SOX2
Interaction	IKBKG interactions	MYC LNX2 TES TRIM31 SRPK1 PRKD3 LENG8 TRIM37 KPNA1	2.88e-04	458	94	9	int:IKBKG
Interaction	KRT5 interactions	MYC KRT32 TRIM31 CHD3 WTAP TRIM37	2.89e-04	193	94	6	int:KRT5
Cytoband	7p22.1	ERVK-6 RSPH10B2 RSPH10B	1.43e-04	47	98	3	7p22.1
Cytoband	6q14.3	CEP162 ZNF292	6.75e-04	18	98	2	6q14.3
Cytoband	19p13	CLEC4M CD209	1.53e-03	27	98	2	19p13
Cytoband	14q22.1	KTN1 ATL1	1.89e-03	30	98	2	14q22.1
GeneFamily	Regulatory factor X family	RFX8 RFX1	2.70e-04	8	57	2	1153
GeneFamily	Kelch like\|BTB domain containing	KLHL7 KLHL15 KLHL18	3.13e-04	42	57	3	617
GeneFamily	Zinc fingers C2H2-type\|Sp transcription factors	SP2 SP3	3.47e-04	9	57	2	755
GeneFamily	Zinc fingers\|Zinc fingers PARP-type\|Poly(ADP-ribose) polymerases	PARP3 PARP4	1.29e-03	17	57	2	684
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	SP2 SP3 HIVEP1 ZNF518A HINFP PRDM10 ZNF335 ZNF292	1.76e-03	718	57	8	28
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	PRKD2 PLEKHG4 VEPH1 PRKD3	4.04e-03	206	57	4	682
GeneFamily	Zinc fingers FYVE-type\|Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors	RBSN ZFYVE9	4.28e-03	31	57	2	81
Coexpression	KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3	MYC LNX2 TES MBNL1 AGGF1 CHD3 HNRNPK PARP4 TSC22D1 PRDM10 MTMR11 ZNF335 AMOTL2 KPNA1	1.07e-06	843	90	14	M2356
Coexpression	GSE24671_CTRL_VS_SENDAI_VIRUS_INFECTED_MOUSE_SPLENOCYTES_DN	SLC9A9 CHD3 RFX1 PRRC2C PRRC2B RAI1 ZNF292	5.74e-06	199	90	7	M9443
Coexpression	GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP	KNTC1 SLC9A9 SETD2 PRDM10 PRRC2C KLHL18	3.73e-05	180	90	6	M8239
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	PRKD2 SP3 KTN1 MBNL1 AGGF1 RNF213 CHD3 PRKD3 ZMAT3 SETD2 SETD5 RORA ZFR SNRNP200 PRRC2B ZNF292	4.41e-05	1492	90	16	M40023
Coexpression	GSE30971_WBP7_HET_VS_KO_MACROPHAGE_DN	KTN1 ATL3 LDLRAD3 WTAP ZFR GOLGA2	6.51e-05	199	90	6	M8721
Coexpression	GSE339_CD8POS_VS_CD4CD8DN_DC_IN_CULTURE_DN	PRKD2 PRKD3 KLHL7 RORA ZNF292 KPNA1	6.69e-05	200	90	6	M5128
Coexpression	GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4HIGH_BCELL_UP	HNRNPK TSC22D1 SETD5 BBS12 TRIM37 PLIN3	6.69e-05	200	90	6	M9838
ToppCell	severe-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	MBNL1 RNF213 CHD3 PRRC2C GCC2 RORA SNRNP200 ZNF292	6.68e-09	197	90	8	57ebd552f10d6278623b52a3d484d4b91ae1d028
ToppCell	human_hepatoblastoma\|World / Sample and Cell Type and Tumor Cluster (all cells)	DCDC2 HIVEP1 MBNL1 SETD5 PRRC2C GCC2 ZNF292	1.33e-07	193	90	7	e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCell	facs-Marrow-KLS-3m-Lymphocytic-immature_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KNTC1 KLHL15 ATL2 BBS12 WNK2 PRRC2B	1.41e-06	173	90	6	8bffd512a4e561e23cc04478e2ca6fd5d3771fe4
ToppCell	facs-Marrow-KLS-3m-Lymphocytic-immature_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KNTC1 KLHL15 ATL2 BBS12 WNK2 PRRC2B	1.41e-06	173	90	6	3e3c61468e703330788a10d850ef41a85680f86d
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1\|TCGA-Pancreas / Sample_Type by Project: Shred V9	CASP8AP2 SP3 KIF16B PARP4 PRDM10 GCC2	2.15e-06	186	90	6	03db813598b67b1e08f759758a1c2023396921fa
ToppCell	3'-Adult-Distal_Rectal\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	KTN1 MBNL1 TRIM31 MTMR11 PRRC2C GCC2	3.08e-06	198	90	6	7ad7726fc405806b1d7824f58548073ea5e0c70b
ToppCell	3'-Adult-Distal_Rectal-Epithelial-epithelial_progenitor_cell-TA\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	KTN1 MBNL1 TRIM31 MTMR11 PRRC2C GCC2	3.08e-06	198	90	6	1fbec311f2c987ca90a023a5989128c05aa12d5c
ToppCell	3'-Adult-Distal_Rectal-Epithelial\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	KTN1 MBNL1 TRIM31 MTMR11 PRRC2C GCC2	3.08e-06	198	90	6	ceede961ad9af6a3159db7efaa5087bf38aafc2d
ToppCell	3'-Adult-Distal_Rectal-Epithelial-epithelial_progenitor_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	KTN1 MBNL1 TRIM31 MTMR11 PRRC2C GCC2	3.08e-06	198	90	6	4f26a60e99f42343e5af7221723e108a1a1b7827
ToppCell	facs-Brain_Myeloid-Cerebellum-3m-Myeloid-nan\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SP3 KTN1 MBNL1 WTAP PRRC2C	2.68e-05	173	90	5	869da6a65d1b9b7529c666ec44e3c8ddec2ea408
ToppCell	facs-Brain_Myeloid-Cerebellum-3m-Myeloid\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SP3 KTN1 MBNL1 WTAP PRRC2C	2.68e-05	173	90	5	0672bd8a4a9d18af343d01f09253fb3388896c10
ToppCell	facs-Brain_Myeloid-Cerebellum-3m\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SP3 KTN1 MBNL1 WTAP PRRC2C	2.68e-05	173	90	5	870e091ec30be01a900e1cb8b9ef1880e3b7b50d
ToppCell	PND14-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Deuterosomal\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DCDC2 NEK10 RIBC1 CEP128 CROCC2	3.24e-05	180	90	5	5c9d2d44d840cd4ec7d42d43446ba2b689e7ec43
ToppCell	PND14-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Deuterosomal-Deuterosomal_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DCDC2 NEK10 RIBC1 CEP128 CROCC2	3.24e-05	180	90	5	c60e74fbbd815a0251253a19dc520a254b2e1762
ToppCell	droplet-Marrow-nan-3m-Hematologic-nan\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CASP8AP2 MBNL1 CHD3 PRRC2C GCC2	3.41e-05	182	90	5	e78ba2c5cae480c16a596ce7c3bf2d480becacf4
ToppCell	droplet-Marrow-nan-3m-Hematologic\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CASP8AP2 MBNL1 CHD3 PRRC2C GCC2	3.41e-05	182	90	5	1710eab3037a87609d21838be2d2d29c3bc36651
ToppCell	cellseq2-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-NK\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	PRKD2 CEP128 ZNF335 KLHL15 KPNA1	3.41e-05	182	90	5	8ccffcbae28c374fd4161fb0d4cf2c49fae557f6
ToppCell	droplet-Marrow-nan-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KTN1 MBNL1 SETD2 PRRC2C GCC2	3.59e-05	184	90	5	1154a5ad7b8512272b7476f949ddac350910bfb7
ToppCell	PBMC-Convalescent-Hematopoietic-Platelet-Platelet-plt_4\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	VEPH1 MYZAP ATL1 TSC22D1 BBS12	3.69e-05	185	90	5	709236097cbfc254796fcc69b5f5178b73dad9bd
ToppCell	PBMC-Convalescent-Hematopoietic-Platelet-Platelet-plt_4\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	VEPH1 MYZAP ATL1 TSC22D1 BBS12	3.69e-05	185	90	5	af078a6c4a3e0b54b7d8ab7b30dcd06053ebfd28
ToppCell	mild_COVID-19-Platelet\|World / disease group, cell group and cell class (v2)	VEPH1 MYZAP ATL1 TSC22D1 MINDY1	4.08e-05	189	90	5	038ec3c266b89416bb5b774ba522d916394961da
ToppCell	PBMC-Mild-Hematopoietic-Platelet-Platelet-plt_1\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	VEPH1 MYZAP ATL1 TSC22D1 MINDY1	4.19e-05	190	90	5	b719061be370ffc293854f1f6e526bf33cd2f442
ToppCell	PBMC-Mild-Hematopoietic-Platelet-Platelet-plt_1\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	VEPH1 MYZAP ATL1 TSC22D1 MINDY1	4.19e-05	190	90	5	427038bae9c7b3a9441c8d59ace69da74e9d37bf
ToppCell	COVID-19_Mild-Hematopoietic_Mega-Platelet\|COVID-19_Mild / Disease group, lineage and cell class	VEPH1 MYZAP ATL1 TSC22D1 MINDY1	4.29e-05	191	90	5	6b3cfc670f69ed3e757cbf7498943e549e31326e
ToppCell	mild_COVID-19-Platelet\|mild_COVID-19 / disease group, cell group and cell class (v2)	VEPH1 MYZAP ATL1 TSC22D1 MINDY1	4.29e-05	191	90	5	968e2d48969884dd21b8a87f199af94a7410b0dd
ToppCell	severe-low-quality_cells\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	MBNL1 RNF213 RSPH10B2 RORA ZNF292	4.51e-05	193	90	5	9337bc93e3904c7fc7c93c328518bcd6453b1e8c
ToppCell	COVID_non-vent-Lymphocytic-T_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	MYC MBNL1 CHD3 GCC2 RORA	4.74e-05	195	90	5	4bdedd924564a260841a9153604026b57487c83d
ToppCell	(1)_T_cells-(1)_T_CD4_naive\|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1)	MYC MBNL1 CHD3 SETD2 GCC2	4.74e-05	195	90	5	d3fa551bc6f5ee5890af1040415e61ecd5d46201
ToppCell	COVID-19_Severe\|World / Disease condition and Cell class	MYC KTN1 MBNL1 CHD3 PRRC2C	4.85e-05	196	90	5	450ac2aff89c5ca73b8bfbc80663e03be066931f
ToppCell	droplet-Tongue-TONGUE\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KRT32 KTN1 PPL PRRC2C RORA	4.85e-05	196	90	5	44a30b1a5f3d8c845e5f3bd17d8102a7449f555b
ToppCell	droplet-Tongue-TONGUE-1m\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KRT32 KTN1 PPL PRRC2C RORA	4.85e-05	196	90	5	9935bdb10789e8cfc922dca526ca3bf8317fe270
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DCDC2 NEK10 VEPH1 PPL ZFHX4	4.85e-05	196	90	5	c7136b1c83bcf907eec3b02b151fa061298b6672
ToppCell	droplet-Tongue-TONGUE-1m-Epithelial\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KRT32 KTN1 PPL PRRC2C RORA	4.85e-05	196	90	5	a85f5f1e6acc798e9e02b1a21e0ffe87a323c333
ToppCell	COVID_non-vent-Lymphocytic\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	MYC MBNL1 CHD3 GCC2 RORA	4.97e-05	197	90	5	c672915f8c8c1e948d251f6eaf9f84a5600c1193
ToppCell	COVID_vent-Lymphocytic-T_cell\|COVID_vent / Disease condition, Lineage, Cell class and subclass	MYC MBNL1 CHD3 GCC2 RORA	4.97e-05	197	90	5	ad702e440a74d54cfdcb8bb1c66bd8e0e71ab04e
ToppCell	COVID_vent-Lymphocytic-T_cell-CD4+_Memory_T_cell\|COVID_vent / Disease condition, Lineage, Cell class and subclass	MYC MBNL1 CHD3 GCC2 RORA	5.09e-05	198	90	5	58f208b76cb0adcecdf632d92f92833a06f9bf71
ToppCell	moderate-Lymphoid-CTL\|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	KTN1 MBNL1 RNF213 PRRC2C RORA	5.09e-05	198	90	5	0a868098b1ee4b28b2149ed766acb09e9c0ce14c
ToppCell	mild-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	RNF213 PRRC2C RORA SNRNP200 ZNF292	5.22e-05	199	90	5	f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell	(10)_Ciliated-(2)_GFP_FOXI1\|(10)_Ciliated / shred by cell type by condition	CEP162 KTN1 PRRC2C GCC2 ZFR	5.22e-05	199	90	5	61b1ed2db71b96157b92b7535d1955a4033098da
ToppCell	(00)_Basal-(2)_GFP_FOXI1\|(00)_Basal / shred by cell type by condition	KTN1 PRRC2C GCC2 ZFR ZNF292	5.22e-05	199	90	5	19674e1eaeb51e4196d847cb62aa437c852951d3
ToppCell	(04)_Interm._basal>secr.-(2)_GFP_FOXI1\|(04)_Interm._basal>secr. / shred by cell type by condition	KTN1 PRRC2C GCC2 ZFR ZNF292	5.22e-05	199	90	5	53ca3861f9e00dab3f3fbefb0837857ee39ab084
ToppCell	(05)_Secretory-(2)_GFP_FOXI1\|(05)_Secretory / shred by cell type by condition	KTN1 PRRC2C GCC2 KDSR ZNF292	5.22e-05	199	90	5	d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098
ToppCell	(01)_IL1RL1+-(2)_GFP_FOXI1\|(01)_IL1RL1+ / shred by cell type by condition	KTN1 PRRC2C GCC2 ZFR ZNF292	5.22e-05	199	90	5	a2f7d0cabf35b80fe239fae34a77bf9344d5d743
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	MBNL1 RNF213 SETD2 PRRC2C ZNF292	5.34e-05	200	90	5	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	Neuronal-Excitatory-eB(RORB)-SEMA3E-\|Neuronal / cells hierarchy compared to all cells using T-Statistic	SLC9A9 LNX2 LDLRAD3 PTPRT PARP4	5.34e-05	200	90	5	1a3d29a580d1b405a74869a1da3e818c581fc559
ToppCell	Neuronal-Excitatory-eB(RORB)-SEMA3E---L4-6\|Neuronal / cells hierarchy compared to all cells using T-Statistic	SLC9A9 LNX2 LDLRAD3 PTPRT PARP4	5.34e-05	200	90	5	6f9ed8fe9cda91185c3a1a675353e11b8fec6ef1
ToppCell	Neuronal-Excitatory-eB(RORB)-SEMA3E--\|Neuronal / cells hierarchy compared to all cells using T-Statistic	SLC9A9 LNX2 LDLRAD3 PTPRT PARP4	5.34e-05	200	90	5	86705dfc05b3e1576543b93883c88fb55b742855
ToppCell	Neuronal-Excitatory-eB(RORB)-SEMA3E\|Neuronal / cells hierarchy compared to all cells using T-Statistic	SLC9A9 LNX2 LDLRAD3 PTPRT PARP4	5.34e-05	200	90	5	db194b4f524fd008b3c5b4b6014b436190a1b87a
ToppCell	severe-CD4+_Tcm\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	MYC PRRC2C GCC2 RORA KDSR	5.34e-05	200	90	5	e83558090a079dd9e40e0d3b5d9917fbd2695ec4
ToppCell	343B-Lymphocytic-NK_cells-NK_cell_A2\|343B / Donor, Lineage, Cell class and subclass (all cells)	SP3 CEP162 AGGF1 FCHSD1	1.53e-04	133	90	4	8ff1cf0ea1fc33fe8384c0e65c1ee1853b25a2ae
ToppCell	(08)_Brush+PNEC-(2)_GFP_FOXI1\|(08)_Brush+PNEC / shred by cell type by condition	PRRC2C GCC2 ZFR ZNF292	1.76e-04	138	90	4	817e3f639604ea95adae01e8685ffaa2e0aff7a8
ToppCell	3'_v3-Lung-Lymphocytic_T_CD4-Tfh\|Lung / Manually curated celltypes from each tissue	NEK10 TRIM31 RFX8 RORA	1.97e-04	142	90	4	319812c84fad93276bf093f2ad78db02ae745bf4
Drug	isobenzofuran	SP2 SP3 PPL	2.21e-06	7	92	3	CID011378474
Drug	Le(x	CLEC4M CD209 TRIM37	5.27e-06	9	92	3	CID004571095
Disease	hereditary spastic paraplegia 3A (implicated_via_orthology)	ATL3 ATL1 ATL2	2.65e-08	3	89	3	DOID:0110791 (implicated_via_orthology)
Disease	Intellectual Disability	CHD3 ATL1 HNRNPK SETD2 ZNF335 KLHL15 RORA RAI1 ZNF292	8.45e-06	447	89	9	C3714756
Disease	hereditary spastic paraplegia (implicated_via_orthology)	ATL3 ATL1 ATL2 BORCS7	8.72e-06	43	89	4	DOID:2476 (implicated_via_orthology)
Disease	extrapulmonary tuberculosis (is_implicated_in)	CLEC4M CD209	2.69e-05	3	89	2	DOID:0050598 (is_implicated_in)
Disease	Hereditary Sensory Autonomic Neuropathy, Type 1	ATL3 ATL1	2.49e-04	8	89	2	C0020071
Disease	prostate carcinoma	SP3 MBNL1 TRIM31 RNF213 CHD3 WTAP PPL QSER1 HTR3B KDSR	3.54e-04	891	89	10	EFO_0001663
Disease	lymphocyte percentage of leukocytes	HIVEP1 MBNL1 CLEC4M LDLRAD3 PRKD3 SETD2 BBS12 ZNF292	9.07e-04	665	89	8	EFO_0007993
Disease	acute graft vs. host disease, donor genotype effect measurement	AGGF1 RORA	9.21e-04	15	89	2	EFO_0004599, EFO_0007892
Disease	attention deficit hyperactivity disorder, schizophrenia	RORA MINDY1 RAI1	9.68e-04	64	89	3	EFO_0003888, MONDO_0005090
Disease	response to acetylsalicylate	SETD2 KLHL18	1.05e-03	16	89	2	GO_1903492
Disease	autosomal dominant intellectual developmental disorder (is_implicated_in)	SETD2 ZNF292	1.19e-03	17	89	2	DOID:0060307 (is_implicated_in)
Disease	neutrophil percentage of leukocytes	HIVEP1 CLEC4M LDLRAD3 PRKD3 SETD2 BBS12 ZNF292	2.49e-03	610	89	7	EFO_0007990
Disease	Acute kidney injury	SP2 ATL1	2.58e-03	25	89	2	HP_0001919
Disease	Neurodevelopmental Disorders	SETD2 SETD5 ZNF292	2.83e-03	93	89	3	C1535926
Disease	calcium measurement	MBNL1 MYZAP ATL1 HINFP RORA MINDY1 KPNA1	2.93e-03	628	89	7	EFO_0004838

Protein segments in the cluster

Peptide	Gene	Start	Entry
LQQQQQYQYLQQSQE	AMOTL2	256	Q9Y2J4
SQISKQQSNYQDEQG	CEP128	331	Q6ZU80
NLLNDNNIENYSTNA	CAGE1	91	Q8TC20
NQYKENHNRTQQQVE	COPS7B	196	Q9H9Q2
QSISNYLQTQDQTDQ	HTR3B	386	O95264
LYQNAESNNQELRTQ	AGGF1	56	Q8N302
TVEDQYKQLNQQHSQ	ANGPTL3	181	Q9Y5C1
SISQEQSRQDAIYQN	CD209	66	Q9NNX6
NEAVQAQNNTYRTGI	BBS12	71	Q6ZW61
VEEAVQLQYQNACVQ	BBS12	286	Q6ZW61
ENYQDQNNSSINTVK	CASP8AP2	1216	Q9UKL3
EKEEQLAQYQANANQ	KIF16B	951	Q96L93
SGRLSYDQQQQQQQQ	RAI1	271	Q7Z5J4
QENLRQLQDEYDQQQ	RBSN	486	Q9H1K0
SNQQEVLSSVTNENY	QSER1	396	Q2KHR3
NQTNIENNNNKFYII	PARP3	71	Q9Y6F1
RQNVQQNEDATQYEE	RSPH10B	61	P0C881
RQNVQQNEDASQYEE	RSPH10B2	61	B2RC85
NNGIQYVASQAEQNA	LDLRAD3	236	Q86YD5
IVQARAQSNQAQQYS	MTMR11	161	A4FU01
QQVATSSEQLQNYQS	KRT32	296	Q14532
ASEGTINQEIQRYQQ	KIAA1109	3561	Q2LD37
QYVSQAEASALQQQQ	LENG8	71	Q96PV6
DQILQVNNYNISNVS	LNX2	281	Q8N448
NDTNAHQVVQENGVY	NEK10	401	Q6ZWH5
EQEVQKICANSQQYQ	PPL	781	O60437
SDYQTNNNDQAVVEI	VEPH1	46	Q14D04
AQQLQQEEYQQQQAA	MINDY1	416	Q8N5J2
NSQIQENVDIATVYQ	PRKD2	536	Q9BZL6
NCQIQENVDISTVYQ	PRKD3	561	O94806
QIEQLKQQNYQQASS	KTN1	976	Q86UP2
NTNNITELVNYLAND	KNTC1	2156	P50748
SNNVQSLLDAANQYQ	KLHL7	111	Q8IXQ5
QVAYVQQDATAQQAS	PRDM10	86	Q9NQV6
DPQTNSQQQTTQYII	PRDM10	1116	Q9NQV6
DNADVLSQYQLNSIQ	PARP4	51	Q9UKK3
KSQEAQSLQQQRDQY	GOLGA2	601	Q08379
NQQQYEAEEVIQTSS	PTPRT	431	O14522
QSAQYSQQLQAARNE	FCHSD1	196	Q86WN1
AQSTQNVDYNQLQEV	ERVK-10	141	P87889
AQSTQNVDYNQLQEV	ERVK-19	141	Q9YNA8
AQSTQNVDYNQLQEV	ERVK-21	141	P62683
AQSTQNVDYNQLQEV	ERVK-24	141	P63145
AQSTQNVDYNQLQGV	ERVK-5	141	Q9HDB9
AQSTQNVDYNQLQEV	ERVK-6	141	Q7LDI9
AQSTQNVDYNQLQEV	ERVK-7	141	P63130
AQSTQNVDYNQLQEV	ERVK-8	141	P62685
AQSTQNVDYNQLQEV	ERVK-9	141	P63126
AQSTQNADYNQLQEV	HERVK_113	141	P62684
EVDQALNYFQNVHQQ	KLHL15	251	Q96M94
AYNGNLAIDQQNVQS	KLHL18	96	O94889
SSIQVYNLSQNVQED	ATL1	171	Q8WXF7
QEAQSQQEQAQATIS	CROCC2	971	H7BZ55
QVNYNDAAQEDQDNQ	CHD3	1346	Q12873
NSQHYQKNINSLQEE	GCC2	226	Q8IWJ2
QVYNLSQNIQEDDLQ	ATL2	201	Q8NHH9
QEQETLLQGYQQENE	CEP162	711	Q5TB80
IYNLSQNIQEDDLQQ	ATL3	171	Q6DD88
QYQQEAIQKNVEQSS	BORCS7	81	Q96B45
QYQVNQAAAAQAAAT	MBNL1	251	Q9NR56
TNLNSQQVIYSDNNG	MAN2B2	721	Q9Y2E5
ETRQQLAQYQQQQSQ	WTAP	231	Q15007
VVNQTNAQGQQEIVY	HINFP	466	Q9BQA5
QDYNQVENVIKQAQE	KDSR	96	Q06136
EENENNQQNKDYAAV	DCDC2	461	Q9UHG0
SSNLVNIDQNGNVEY	PPEF1	526	O14829
QSFNQLVYHQNEIVQ	UTP20	76	O75691
IEEAAQNYQGQIQEQ	TRIM31	131	Q9BZY9
QLEAAQTSYIQQINN	TRIM37	421	O94972
ELIFSNEYTQAENQN	TES	306	Q9UGI8
IVNQDELAINYQEQA	SLC9A9	581	Q8IVB4
AQGSFQELYQVAQEQ	PLEKHG4	491	Q58EX7
TGLSDISAQVQQYQQ	RFX1	561	P22670
QVDLNQQQYIFQQCE	KPNA1	516	P52294
DEEENFYQQQQQSEL	MYC	26	P01106
QDQIQNAQYLLQNSV	HNRNPK	441	P61978
FDVASVQQQRQEQSY	PLIN3	221	O60664
QQQNPQVYVSQSAAA	PRRC2C	2371	Q9Y520
FTNQYSADVQNALEQ	SETD5	221	Q9C0A6
QVQLQSQELSYQQKQ	TSC22D1	546	Q15714
EVINYTQNSNNETLR	SRPK1	361	Q96SB4
AQSNEQGQVCYQELV	RHBDL1	116	O75783
AQSTQNVDYNQLQEV	ERVK-9	141	P63128
QEQSEQDAIYQNLTQ	CLEC4M	81	Q9H2X3
QTYASDQVQNNGLID	CLCA1	456	A8K7I4
QNQDLDTFQYQEGSV	RNF213	2176	Q63HN8
LLQQYQQYQQNLQES	ZFHX4	3266	Q86UP3
RQQQEQQQAKVDENY	RIBC1	166	Q8N443
QTFLQEEIENYQNKQ	RORA	301	P35398
QYQAVPQIQASNSQT	SP2	131	Q02086
NYIQSPVSEETQAQN	SP3	371	Q02447
IYVETCGQNTENQVN	RFX8	46	Q6ZV50
GETSQNAQINYNIQL	ZNF292	1781	O60281
QQQSYQQAAAAQQIP	PRRC2B	1946	Q5JSZ5
QNIDGQNLYSNENQN	ZNF518A	726	Q6AHZ1
NQQSVSVQQQYSPAQ	SETD2	2276	Q9BYW2
IQTQVFNTVYNSDDN	SNRNP200	1331	O75643
QGATQYTQAQQTRQV	ZFR	196	Q96KR1
NVTLNSAQQAQAHYQ	ZMAT3	76	Q9HA38
SRQSQANAPVYQQNV	WNK2	1291	Q9Y3S1
DNQVQYIISQDGVQH	ZNF335	1221	Q9H4Z2
LQRQQATDYSQEQQG	HIVEP1	646	P15822
VQNDDGNYQTQAISI	ZFYVE9	1176	O95405
AQQEYLENHIQTQSS	MYZAP	141	P0CAP1